1. Home
  2. PCVX vs CX Comparison

PCVX vs CX Comparison

Compare PCVX & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • CX
  • Stock Information
  • Founded
  • PCVX 2013
  • CX 1906
  • Country
  • PCVX United States
  • CX Mexico
  • Employees
  • PCVX N/A
  • CX N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • CX Building Materials
  • Sector
  • PCVX Health Care
  • CX Industrials
  • Exchange
  • PCVX Nasdaq
  • CX Nasdaq
  • Market Cap
  • PCVX 4.4B
  • CX 8.6B
  • IPO Year
  • PCVX 2020
  • CX 1999
  • Fundamental
  • Price
  • PCVX $33.10
  • CX $7.08
  • Analyst Decision
  • PCVX Strong Buy
  • CX Buy
  • Analyst Count
  • PCVX 10
  • CX 5
  • Target Price
  • PCVX $136.50
  • CX $7.45
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • CX 12.1M
  • Earning Date
  • PCVX 08-05-2025
  • CX 07-24-2025
  • Dividend Yield
  • PCVX N/A
  • CX 1.19%
  • EPS Growth
  • PCVX N/A
  • CX 591.00
  • EPS
  • PCVX N/A
  • CX 0.10
  • Revenue
  • PCVX N/A
  • CX $15,906,684,000.00
  • Revenue This Year
  • PCVX N/A
  • CX $3.44
  • Revenue Next Year
  • PCVX N/A
  • CX $3.26
  • P/E Ratio
  • PCVX N/A
  • CX $7.33
  • Revenue Growth
  • PCVX N/A
  • CX N/A
  • 52 Week Low
  • PCVX $27.66
  • CX $4.89
  • 52 Week High
  • PCVX $121.06
  • CX $7.34
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 42.61
  • CX 57.57
  • Support Level
  • PCVX $32.06
  • CX $6.67
  • Resistance Level
  • PCVX $33.81
  • CX $6.98
  • Average True Range (ATR)
  • PCVX 1.23
  • CX 0.17
  • MACD
  • PCVX -0.16
  • CX -0.01
  • Stochastic Oscillator
  • PCVX 8.44
  • CX 55.72

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About CX Cemex S.A.B. de C.V. Sponsored ADR

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.

Share on Social Networks: